Immunotherapy News and Research

Latest Immunotherapy News and Research

ASCO announces cancer Advance of the Year

ASCO announces cancer Advance of the Year

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Tübingen researchers develop new way of labeling T-cells

Tübingen researchers develop new way of labeling T-cells

CAR T-cell therapy enters into Phase I clinical trial

CAR T-cell therapy enters into Phase I clinical trial

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Study assesses therapeutic benefits of new oral immunotherapy for children allergic to wheat

Study assesses therapeutic benefits of new oral immunotherapy for children allergic to wheat

TxCell announces further enhancement to development of Ovasave for IBD treatment

TxCell announces further enhancement to development of Ovasave for IBD treatment

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

Top cancer research and clinical developments at Dana-Farber Cancer Institute in 2014

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

Pivotal trial of Elios melanoma vaccine to be conducted at top U.S. cancer hospitals

Pivotal trial of Elios melanoma vaccine to be conducted at top U.S. cancer hospitals

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents starts trading on The Nasdaq Capital Market

Scientists identify white blood cells that tumors use to suppress disease-fighting immune system

Scientists identify white blood cells that tumors use to suppress disease-fighting immune system

Inovio begins hTERT DNA immunotherapy trial in adults with breast, lung and pancreatic cancer

Inovio begins hTERT DNA immunotherapy trial in adults with breast, lung and pancreatic cancer

EC grants orphan drug designation to TxCell's Col-Treg for treatment of autoimmune uveitis

EC grants orphan drug designation to TxCell's Col-Treg for treatment of autoimmune uveitis

Scientists produce novel class of molecules that could help combat cancer, other diseases

Scientists produce novel class of molecules that could help combat cancer, other diseases

OncoTherapy Network discusses latest research on prostate cancer

OncoTherapy Network discusses latest research on prostate cancer

PD-L1 expression tied to favourable prognosis in SCLC

PD-L1 expression tied to favourable prognosis in SCLC

Kiadis Pharma reports positive interim data from ATIR Phase II clinical study

Kiadis Pharma reports positive interim data from ATIR Phase II clinical study

Study: Injectable 3D vaccines could help prevent cancer, infectious disease

Study: Injectable 3D vaccines could help prevent cancer, infectious disease

Amgen announces new data from BLINCYTO Phase 2 study for treatment of patients with ALL

Amgen announces new data from BLINCYTO Phase 2 study for treatment of patients with ALL

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.